Drug samples: friend or foe?
The common practice of drug manufacturers in providing 'free' samples to physicians has influenced the business of medicine in several ways. This article analyzes some of the pros and cons of drug sampling, including from professional, societal, economical, legal, and practical perspectives, and provides suggestions on how to dispense with some of the problems inherent in the current system.
Coolidge
Melvin P
MP
Yale University School of Medicine, 79 South Benson Road, Fairfield, CT 06430, USA. mpcoolidgemd@aol.com
D000329:Advertising / Q000191:economics / Q000379:methods*; D000529:Complementary Therapies; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D007591:Joint Commission on Accreditation of Healthcare Organizations; D004364:Pharmaceutical Preparations; D010818:Practice Patterns, Physicians'; D014481:United States
D004364:Pharmaceutical Preparations